ISIN | LU0432979614 |
---|---|
Valor Number | 10261626 |
Bloomberg Global ID | |
Fund Name | JPM Global Healthcare Fund A acc USD |
Fund Provider |
J.P. Morgan Bank Luxembourg S.A.
6, route de Trèves L-2633, Senningerberg Grand Duchy of Luxembourg |
Fund Provider | J.P. Morgan Bank Luxembourg S.A. |
Representative in Switzerland |
JPMorgan Asset Management (Switzerland) LLC Genève Phone: +41 22 744 11 11 |
Distributor(s) |
JP Morgan Asset Management (Europe) Sàrl Senningerberg Phone: +352 34 10 1 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. |
Peculiarities |
Current Price * | 496.70 USD | 03.10.2025 |
---|---|---|
Previous Price * | 493.97 USD | 02.10.2025 |
52 Week High * | 530.89 USD | 14.10.2024 |
52 Week Low * | 437.54 USD | 15.05.2025 |
NAV * | 496.70 USD | 03.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 3,565,491,166 | |
Unit/Share Assets *** | 913,989,186 | |
Trading Information SIX |
YTD Performance | +6.13% |
31.12.2024 - 03.10.2025
31.12.2024 03.10.2025 |
---|---|---|
YTD Performance (in CHF) | -6.76% |
31.12.2024 - 03.10.2025
31.12.2024 03.10.2025 |
1 month | +4.77% |
03.09.2025 - 03.10.2025
03.09.2025 03.10.2025 |
3 months | +7.06% |
03.07.2025 - 03.10.2025
03.07.2025 03.10.2025 |
6 months | +2.90% |
03.04.2025 - 03.10.2025
03.04.2025 03.10.2025 |
1 year | -5.48% |
03.10.2024 - 03.10.2025
03.10.2024 03.10.2025 |
2 years | +12.45% |
03.10.2023 - 03.10.2025
03.10.2023 03.10.2025 |
3 years | +12.65% |
03.10.2022 - 03.10.2025
03.10.2022 03.10.2025 |
5 years | +16.54% |
05.10.2020 - 03.10.2025
05.10.2020 03.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AbbVie Inc | 7.78% | |
---|---|---|
Johnson & Johnson | 7.62% | |
Eli Lilly and Co | 6.12% | |
AstraZeneca PLC | 5.08% | |
Boston Scientific Corp | 4.22% | |
Roche Holding AG | 4.00% | |
Stryker Corp | 3.57% | |
Danaher Corp | 3.46% | |
UnitedHealth Group Inc | 2.88% | |
CVS Health Corp | 2.81% | |
Last data update | 31.08.2025 |
TER *** | 1.69% |
---|---|
TER date *** | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.69% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |